Regulatory Digest: DEA Enforcement & Controlled Substances March 2026
This regulatory digest covers DEA enforcement controlled substances updates relevant to cannabis and synthetic cannabinoid importation. The March 2026 notices highlight scheduling changes and import restrictions. Clinicians should stay informed about…
Adolescent Cannabis Psychiatric Outcomes: New 2026 Insights
Recent research highlights adolescent cannabis psychiatric outcomes, emphasizing risks linked to teen cannabis use. The developing brain is vulnerable to cannabis effects, increasing psychiatric disorder risks. This 2026 digest presents new insights into…
WAFB – Louisiana Lawmaker Files Bill to Legalize Recreational Marijuana
A louisiana recreational marijuana legalization bill has been introduced by a state legislator, proposing licensed dispensary sales. This bill marks a significant shift in louisiana cannabis policy. The legislation could expand legal access beyond…
Study Highlights Pros and Cons of Medical Marijuana in Tennessee
This study highlights medical cannabis benefits and risks as Tennessee faces uncertain policy changes. Clinicians must navigate evolving evidence to counsel patients effectively. Federal rescheduling may soon improve research and prescribing clarity.
Firefighters Move Closer to Medical Cannabis Access
Medical cannabis firefighters policies are evolving to address occupational health challenges. Firefighters face chronic pain and PTSD where cannabis may offer alternatives to opioids. This shift could expand treatment options for first responders.
Lawmakers Strike Down Bill Capping THC Levels in Oregon’s Cannabis Edibles
Oregon cannabis industry beats THC potency cap in edibles, allowing higher THC concentrations in products. This affects clinicians who must counsel patients on safe dosing and risks. The absence of potency limits increases the risk of accidental…
The Wait is Over: Medical Cannabis Set to Roll Out in Alabama
Alabama medical cannabis dispensaries eager to open in April will expand patient access to cannabis-based therapeutics. Clinicians must prepare to educate patients on dosing, formulations, and drug interactions. This rollout marks a significant step in…
Kids as Young as 11 Being Treated for Cannabis Use Disorder, Children’s National Hospital Says
Cannabis use disorder in children is an emerging concern requiring early screening and intervention. Children as young as 11 are being treated for this disorder. Understanding youth cannabis accessibility helps inform prevention strategies.
Policy Regulation Cannabis Patient Access Challenges
This digest highlights policy regulation cannabis patient access challenges that persist despite legalization. Patients face barriers due to regulatory gaps that limit real access. Understanding these issues is crucial for clinicians and patients alike.
Cannabinoid Clinical Trials: GLP-1 Receptors and Mental Health
The GLP-1 receptor agonists mental health study reveals potential protective effects against schizophrenia and other psychiatric conditions. This Mendelian randomization analysis uses genetic proxies to explore causal relationships. Findings suggest…